Provided by Tiger Trade Technology Pte. Ltd.

Pacira Pharmaceuticals

36.31
-0.0800-0.22%
Post-market: 36.310.00000.00%19:59 EDT
Volume:4.69M
Turnover:170.35M
Market Cap:1.45B
PE:103.22
High:36.36
Open:36.33
Low:36.31
Close:36.39
52wk High:36.46
52wk Low:18.80
Shares:39.86M
Float Shares:36.37M
Volume Ratio:0.75
T/O Rate:12.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3518
EPS(LYR):0.1578
ROE:2.05%
ROA:1.48%
PB:2.15
PE(LYR):230.05

Loading ...

Viatris to Buy Pain Therapy Maker Pacira BioSciences for $1.65 Billion

Reuters
·
Oct 08

Viatris - Pacira to Pay Viatris $62 Million Termination Fee Under Specified Circumstances

Reuters
·
Oct 08

Viatris - Pacira to Pay Viatris $62 Mln Termination Fee Under Specified Circumstances - SEC Filing

THOMSON REUTERS
·
Oct 08

Incorrect Alert on Pacira Biosciences' Share Movement Withdrawn

Reuters
·
Oct 08

Pacira Biosciences Shares up 2% Premarket After Viatris to Acquire Co in $1.65 Bln Deal

THOMSON REUTERS
·
Oct 08

Viatris Agrees to Buy Pacira BioSciences for $36.50 a Share in Cash, Valuing Deal at $1.65 Billion

Reuters
·
Oct 08

Viatris - Deal Expected to Close by End of 2026 and be Immediately Accretive

THOMSON REUTERS
·
Oct 08

Viatris - to Buy Pacira for $36.5 Per Share, Equity Value $1.65 Bln

THOMSON REUTERS
·
Oct 08

Viatris Agrees to Acquire Pacira Biosciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies

THOMSON REUTERS
·
Oct 08

Viatris - Pacira to Become Wholly Owned Subsidiary of Viatris; Stock to be Delisted from NASDAQ

THOMSON REUTERS
·
Oct 08

Viatris Inc.: Expect to Fund Transaction Primarily from Excess Cash with Remainder from Short-Term Borrowings

THOMSON REUTERS
·
Oct 08

NASDAQ Trade Halt Halt News Pending at 07:40 Am

Reuters
·
Oct 08

How Investors Are Reacting To Pacira BioSciences Stock Europe Distribution Deal

Simply Wall St.
·
Oct 07

Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), Pacira Pharmaceuticals (PCRX)

TIPRANKS
·
Oct 06

Pacira Grants Stock Options for 3,600 Shares, RSUs for 4,200 Shares to New Hires Under Inducement Plan

Reuters
·
Oct 05

Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize Exparel® in the European Union and United Kingdom

THOMSON REUTERS
·
Oct 05

Pacira Biosciences, - to Receive Undisclosed Upfront Payment, Supply Price, and Royalties from Molteni

THOMSON REUTERS
·
Oct 05

Pacira Biosciences, - Molteni to Launch Exparel in Italy, Germany, Austria, Poland; First Sale Expected in 2027

THOMSON REUTERS
·
Oct 05

Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom

GlobeNewswire
·
Oct 05

Oppenheimer Initiates Pacira Biosciences at Outperform With $32 Price Target

MT Newswires Live
·
Sep 23